Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balance

Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balance

Objective The efficacy of sirolimus in treating severe or refractory systemic lupus erythematosus (SLE) has been confirmed by small-scale clinical trials. However, few studies focused on mild or moderate SLE. Therefore, in this study we elucidated clinical efficacy of add-on sirolimus in patients wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Min Shi, Lin Yang, Jun Ma, Xiaoping Wang, Lu Jin, Meng Ding, Shaoxin Cui, Fei Chang, Hongtao Jin, Aijing Liu, Jinwen Zhao, Jingjing He, Shuran Song
Format: Article
Language:English
Published: BMJ Publishing Group 2024-05-01
Series:Lupus Science and Medicine
Online Access:https://lupus.bmj.com/content/11/1/e001072.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items